Authors:
ENSINGER HA
BECHTEL WD
BIRKE FW
MENDLA KD
MIERAU J
SPECK G
TROGER W
Citation: Ha. Ensinger et al., WAL-2014-FU (TALSACLIDINE) - A PREFERENTIALLY NEURON ACTIVATING MUSCARINIC AGONIST FOR THE TREATMENT OF ALZHEIMERS-DISEASE, Drug development research, 40(2), 1997, pp. 144-157
Citation: Ca. Rizzi et al., REGULATION OF PLASMA-ALDOSTERONE LEVELS BY METOCLOPRAMIDE - A REAPPRAISAL OF ITS MECHANISM FROM DOPAMINERGIC ANTAGONISM TO SEROTONERGIC AGONISM, Neuropharmacology, 36(6), 1997, pp. 763-768
Citation: Cj. Meade et al., IN-VIVO ROLE OF THE ADENOSINE A(3) RECEPTOR - N-6-2-(4-AMINOPHENYL)ETHYLADENOSINE INDUCES BRONCHOSPASM IN BDE RATS BY A NEURALLY-MEDIATED MECHANISM INVOLVING CELLS RESEMBLING MAST-CELLS, The Journal of pharmacology and experimental therapeutics, 279(3), 1996, pp. 1148-1156
Authors:
MIERAU J
SCHNEIDER FJ
ENSINGER HA
CHIO CL
LAJINESS ME
HUFF RM
Citation: J. Mierau et al., PRAMIPEXOLE BINDING AND ACTIVATION OF CLONED AND EXPRESSED DOPAMINE D-2, D-3 AND D-4 RECEPTORS, European journal of pharmacology. Molecular pharmacology section, 290(1), 1995, pp. 29-36
Citation: P. Gmeiner et al., SYNTHESIS, PHARMACOLOGICAL INVESTIGATION AND COMPUTATIONAL STUDIES ONA TRICYCLIC ERGOLINE ANALOG WITH SELECTIVE DOPAMINE AUTORECEPTOR ACTIVITY, Archiv der pharmazie, 328(7-8), 1995, pp. 609-614
Citation: P. Gmeiner et al., SYNTHESIS AND DOPAMINE-RECEPTOR BINDING-STUDIES OF HOMOCHIRAL 8-AMINOPYRIDO[1,2-ALPHA]INDOLES, Archiv der pharmazie, 328(7-8), 1995, pp. 626-628